Abstract
Although thyroid gland function is mainly under the control of pituitary TSH, other factors may also play a role in this process. Iodine is not used only by the thyroid to synthesize thyroid hormones but also directly influences a number of parameters such as thyroid proliferation and function. Thyroid autoregulation has been related to intraglandular content of an unknown putative iodocompound. The thyroid is capable of producing different iodolipids such as 6-iododeltalactone (ILδ) and 2-iodohexadecanal (2-IHDA). Data from different laboratories have shown that these iodolipids can inhibit several thyroid parameters suggesting that these compounds may be the intermediates in the thyroid autoregulation process.
Keywords: Iodine, iodocompounds, iodohexadecanal, iodolactone, iodolipids, thyroid, Thyroid NADPH oxidases, Metilmercaptoimidazol, Phosphatidyl inositol, Propylthiouracil, Urokinase-type plasminogen activator
Current Chemical Biology
Title: Thyroid: Iodine Beyond the Thyronines
Volume: 5 Issue: 3
Author(s): Guillermo J. Juvenal, Lisa Thomasz, Romina Oglio, Marina Perona, Mario A. Pisarev, Luiciano Rossich and Leonardo Salvarredi
Affiliation:
Keywords: Iodine, iodocompounds, iodohexadecanal, iodolactone, iodolipids, thyroid, Thyroid NADPH oxidases, Metilmercaptoimidazol, Phosphatidyl inositol, Propylthiouracil, Urokinase-type plasminogen activator
Abstract: Although thyroid gland function is mainly under the control of pituitary TSH, other factors may also play a role in this process. Iodine is not used only by the thyroid to synthesize thyroid hormones but also directly influences a number of parameters such as thyroid proliferation and function. Thyroid autoregulation has been related to intraglandular content of an unknown putative iodocompound. The thyroid is capable of producing different iodolipids such as 6-iododeltalactone (ILδ) and 2-iodohexadecanal (2-IHDA). Data from different laboratories have shown that these iodolipids can inhibit several thyroid parameters suggesting that these compounds may be the intermediates in the thyroid autoregulation process.
Export Options
About this article
Cite this article as:
J. Juvenal Guillermo, Thomasz Lisa, Oglio Romina, Perona Marina, A. Pisarev Mario, Rossich Luiciano and Salvarredi Leonardo, Thyroid: Iodine Beyond the Thyronines, Current Chemical Biology 2011; 5 (3) . https://dx.doi.org/10.2174/2212796811105030163
DOI https://dx.doi.org/10.2174/2212796811105030163 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Frontiers in Cystic Fibrosis Therapy: The Case of Stem Cells
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) MAPKs as Mediators of Cell Fate Determination: an Approach to Neurodegenerative Diseases
Current Medicinal Chemistry The Interactions Between Diabetes Mellitus and Myelodysplastic Syndromes: Current State of Evidence and Future Directions
Current Diabetes Reviews Endothelial Endocytic Pathways: Gates for Vascular Drug Delivery
Current Vascular Pharmacology Editorial (Thematic Issue: Lutetium-177 Labeled Therapeutics: 177Lu-PSMA is Set to Redefine Prostate Cancer Treatment)
Current Radiopharmaceuticals Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery CircRNAs and Axes Involved in Thyroid Cancer based on PTC: A Biomarker for Prognosis, Diagnosis and Treatment
Current Signal Transduction Therapy Pharmacological Activities and Therapeutic Potential of Kaempferitrin in Medicine for the Treatment of Human Disorders: A Review of Medicinal Importance and Health Benefits
Cardiovascular & Hematological Disorders-Drug Targets Pharmaceutical Strategies Enhancing Cell Penetration Efficiencies of Non-Viral Gene Delivery Systems
Current Gene Therapy Passive Smoking, Asthma and Allergy in Children
Inflammation & Allergy - Drug Targets (Discontinued) Monitoring Intracellular Proteins Using Fluorescence Techniques: From Protein Synthesis and Localization to Activity
Current Protein & Peptide Science Therapeutic Targeting of Cancers with Loss of PTEN Function
Current Drug Targets Tumor-Induced Metabolism and T Cells Located in Tumor Environment
Current Cancer Drug Targets Liver Transporters in Hepatic Drug Disposition: An Update
Current Drug Metabolism Polymorphisms of the Highly Expressed IL-6 Gene in the Papillary Thyroid Cancer Susceptibility Among Chinese
Current Molecular Medicine Correlation between Cancer Antigen 15.3 Value and Qualitative and Semiquantitative Parameters of Positron Emission Tomography/Computed Tomography in Breast Cancer Patients
Current Radiopharmaceuticals S100A8 and S100A9 Overexpression Is Associated with Poor Pathological Parameters in Invasive Ductal Carcinoma of the Breast
Current Cancer Drug Targets MicroRNA Regulation of Programmed Cell Death Pathways in Cancer
Current Chemical Biology Vitamin D, Pit-1, GH, and PRL: Possible Roles in Breast Cancer Development
Current Medicinal Chemistry Regulation of Mitochondrial Biogenesis in Metabolic Syndrome
Current Drug Targets